Integrated transcriptomics reveals master regulators of lung adenocarcinoma and novel repositioning of drug candidates.
Marco Antônio De BastianiFábio KlamtPublished in: Cancer medicine (2019)
Using an integrated transcriptomics approach, we identified master regulator candidates involved with the development and prognostic of lung adenocarcinoma, as well as potential drugs for repurposing.